Palo Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-22,315
Closed -$1.4M 169
2018
Q1
$1.4M Buy
22,315
+959
+4% +$65.8K 0.51% 71
2017
Q4
$1.31M Sell
21,356
-18,904
-47% -$1.17M 0.58% 59
2017
Q3
$2.69M Buy
40,260
+1,593
+4% +$113K 1.42% 23
2017
Q2
$3.01M Sell
38,667
-171
-0.4% -$12.9K 1.7% 14
2017
Q1
$3.17M Buy
38,838
+964
+3% +$75.9K 1.87% 11
2016
Q4
$2.73M Buy
37,874
+16,635
+78% +$1.2M 1.72% 13
2016
Q3
$1.65M Sell
21,239
-16,909
-44% -$1.37M 1.15% 30
2016
Q2
$2.98M Buy
38,148
+18,892
+98% +$1.51M 1.02% 33
2016
Q1
$1.58M Buy
19,256
+1,126
+6% +$91.6K 1.24% 17
2015
Q4
$1.62M Buy
18,130
+225
+1% +$19.1K 1.47% 10
2015
Q3
$1.38M Buy
17,905
+1,010
+6% +$84.4K 1.2% 21
2015
Q2
$1.41M Buy
+16,895
New +$1.49M 1.11% 27

Other funds holding CAH

Palo Capital's CAH Position: Q2 2018 in Review

Palo Capital sold out of Cardinal Health (CAH) in Q2 2018, closing a stake of 22,315 shares — an estimated $1.4M sold.

Palo Capital first reported a position in CAH in Q2 2015 and held it in 12 quarters. The position peaked at $3.17M in Q1 2017. 710 funds tracked by Wall St. Rank hold CAH as of Q2 2018.

  • Palo Capital reported no remaining Cardinal Health position as of Q2 2018 after selling out during the quarter.
  • Palo Capital sold 22,315 Cardinal Health shares in Q2 2018, an estimated $1.4M.
  • Palo Capital first reported a position in Cardinal Health in Q2 2015 and held it in 12 quarters.
  • Palo Capital's Cardinal Health position peaked at $3.17M in Q1 2017.
  • 710 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2018.

Based on Palo Capital's 13F filing for Q2 2018, filed 13 Jul 2018.